Actinium Pharmaceuticals, Inc.
ATNMBiotechnology
$1.53+10.87%As of Oct 29vs prior close
- Market cap
- $48.1M
- P/E (TTM)
- –
- P/E (FY1)
- 10.9×
- From 52W high
- −9.47%
- EPS (YE25)
- -$1.09
- Revenue (YE25)
- $90K
- Net margin
- -37652.22%
- Dividend yield
- 0.00%
Nomior Score
16
Emerging BreakoutSpeculativeBottom 5% of the scored universe
Growth—
Quality12
Value36
Momentum29
Resilience30
Growth
−47.04%revenue a year over 4 fiscal years
YE21 $1.1MYE25 $90K
Connections
Revenue to profitQ2 YE26
80% of revenue became net profit.
Who owns it
1fund